Related Experiment Videos
Calcium channel blockers that prolong the QT interval
American Heart Journal
|February 1, 1985
Summary
New calcium channel blockers prolonging QT intervals may pose proarrhythmic risks. Electrophysiological studies (PES) can identify drugs that induce ventricular tachycardia (VT), aiding in assessing patient safety.
Area of Science:
- Cardiology
- Pharmacology
Background:
- Calcium channel blockers (CCBs) prolonging the QT interval raise concerns about proarrhythmic potential.
- Lidoflazine shows no arrhythmogenic or antiarrhythmic potential in animal models.
- Bepridil exhibits antiarrhythmic effects beyond repolarization prolongation.
Purpose of the Study:
- To assess the proarrhythmic potential of CCBs.
- To evaluate the utility of programmed electrical stimulation (PES) in predicting drug-induced arrhythmias.
Main Methods:
- Animal experiments with lidoflazine.
- Human studies comparing bepridil to procainamide.
- Programmed electrical stimulation (PES) technique to assess arrhythmogenicity and drug effects.
Main Results:
- Lidoflazine demonstrated no arrhythmogenic or antiarrhythmic properties.
- PES effectively identifies electrical instability and predicts antiarrhythmic agent efficacy.
- Factors like alcohol, caffeine, and catecholamines facilitate PES-induced VT, supporting PES for proarrhythmic drug identification.
Conclusions:
- PES is a valuable tool for predicting which drugs may facilitate arrhythmias.
- Understanding drug-induced electrical instability is crucial for patient safety.
- Further assessment of bepridil's antiarrhythmic and proarrhythmic potential is warranted.